Skip to main content

MedUniverse raises additional capital and appoints new Board Members

Press Release   •   Jan 20, 2016 10:26 CET

MedUniverse is accelerating the development and roll-out of its software product, which is customised for the global pharmaceutical and med-tech industries. The MedUniverse software is offered on a subscription basis as a tool for effective product information and education based on interactive patient case studies, with a long run goal of improved patient outcomes. Currently, over twenty international life science companies are subscribing clients.

In January 2016, MedUniverse closed an investment round of 11 MSEK from 20 North Street, a network of investors connected to HDR Partners, as well as from previous owners, to provide resources for accelerated software development, to enable international expansion and to grow the team. Håkan Åström, with extensive experience from the pharmaceutical industry, and Björn Algqvist, Co-Founder of Intentia, have joined the MedUniverse Board of Directors on behalf of 20 North Street.

Anna Omstedt Lindgren, Founding Partner and Board Member of MedUniverse, is enthusiastic about the continued development of the business and welcomes the new owners:

- We are experiencing significantly increased demand for our patient case software as pharmaceutical companies actively search for new digital solutions and effective, data driven communication with physicians and other life science stakeholders. Our new owners and board members further strengthen the experience and knowledge base of MedUniverse and allow us to prepare for a global expansion.

For more information, please contact:
Anna Norin, CEO and Founding Partner MedUniverse, anna.norin@meduniverse.se, +46 (0)70 432 39 15

MedUniverse offers the life science industry an easy-to-use patient case software bridging the information gap to healthcare professionals. In the long run, well-informed decisions improve patient outcomes.